Stay updated on Switch to Dolutegravir + Rilpivirine Clinical Trial

Sign up to get notified when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switch to Dolutegravir + Rilpivirine Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changes from `v3.7.0` to `v3.7.1` while the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T22:50:28.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Access to the study record is now blocked by a 403 Forbidden error page, replacing the prior detailed study content and navigation. This reflects an access restriction rather than a data update to the study record.
    Difference
    20%
    Check dated 2026-09-22T23:04:06.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.7.0, replacing the previous v3.6.6. This reflects a version update to the page rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-09-15T21:55:20.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.5 to v3.6.6, signaling a new release/patch rather than a content alteration. This appears to be a backend/format update rather than a change to study data or visible content.
    Difference
    0.0%
    Check dated 2026-09-01T18:35:31.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    A new line '2014 ( U.S. NIH Grant/Contract )' was added to the study's identifiers. This reflects the NIH funding source for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T21:40:37.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    IPD sharing information and related metadata were added to the study page, including IPD access details and plan descriptions, along with updated revision metadata.
    Difference
    100%
    Check dated 2026-08-11T17:58:32.000Z thumbnail image

Stay in the know with updates to Switch to Dolutegravir + Rilpivirine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.